NCT02464033View on ClinicalTrials.gov

EDCR Study - Etanercept Diamyd Combination Regimen -Open Trial to Evaluate Safety in Children With Type 1 Diabetes

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

February 25, 2019

Study Completion Date

February 25, 2019

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

GAD-Alum

Recombinant Human Glutamic Acid Decarboxylase (rhGAD65)

DRUG

Vitamin D

DRUG

Etanercept

Trial Locations (8)

Unknown

Helsingborg Hospital, Helsingborg

Linköping University Hospital, Linköping

Lund University Hospital, Lund

Skåne University Hospital, UMAS, Malmo

Örebro University Hospital, Örebro

Sachsska, Södersjukhuset, Stockholm

Uddevalla Hospital, Uddevalla

Västerås Hospital, Västerås

Sponsors

Collaborators (1)

Diamyd Medical AB
All Listed Sponsors
collaborator

Swedish Child Diabetes Foundation

OTHER

collaborator

Ostergotland County Council, Sweden

OTHER

collaborator

Diamyd Medical AB

INDUSTRY

lead

Johnny Ludvigsson

OTHER_GOV

NCT02464033 - EDCR Study - Etanercept Diamyd Combination Regimen -Open Trial to Evaluate Safety in Children With Type 1 Diabetes | Biotech Hunter | Biotech Hunter